23rd American Statistical Association Connecticut Chapter Annual Conference
Welcome to the American Statistical Association Connecticut Annual Conference!
Join us for the 23rd Annual ASA (American Statistical Association) Connecticut Chapter Conference! This exciting event will bring together statisticians, data enthusiasts, and industry professionals for a day of learning, networking, and fun. The conference will be hybrid with online option or in person option at Yale School of Public Health in New Haven, CT, USA. Don't miss out on this opportunity to gain insights from expert speakers, participate in engaging workshops, and connect with like-minded individuals. Mark your calendars and get ready for a day filled with knowledge and inspiration! Students and post doc fellows have discount on registration fee, and please reach out to us for the promo code!
Schedule of 23rd Annual ASA (American Statistical Association) Connecticut Chapter Conference on May 16th
Theme: Accelerating Drug Development Through RWE and Complex Innovative Trial Designs
· 8:30 am – 9:30 am: Registration
· 8:30 am – 9:30 am: Refreshment
· 9:00 am – 9:10 am: Opening Remarks and welcome:
-- Birol Emir , ASA CT Chapter Vice President
-- Steven Ma , Yale University School of Public Health
· 9:10 am – 12:00 pm: Scientific Session I
--9:10 am – 9:55 am: Mark van der Laan, UC Berkeley
Super-Efficient Estimation of Average Treatment Effect based on Randomized Controlled Trial Augmented with External Controls or Observational Study Learning;
--10:00 am – 10:45 am: Issa Dahabreh, Harvard University
Augmenting clinical trials using external data and models.
--11:00 am – 11:45 am: Mingyang Shan, Eli Lily
Sensitivity Analysis Strategies for Unmeasured Confounding when Integrating External Controls in Randomized Controlled Trials
· 12:00 pm - 1:00 pm: Lunch
· 1:00 pm – 3:30 pm: Scientific Session II
--1:00 pm – 1:40 pm: Pallavi Mishra-Kalyani, US FDA
Regulatory and Statistical Considerations for Non-randomized Comparative Trials in Drug Development
--1:50 pm – 2:30 pm: Javier Cabrera, Rutgers University
New proposals in clinical study design based on applications of differential Hermite and propensity scores indices.
-- 2:40 pm – 3:15 pm: Discussion, Demissie Alemayehu, Pfizer Inc
-- 3:15 pm – 3:30 pm: Closing Remarks